FINWIRES · TerminalLIVE
FINWIRES

Lumax International's IT Systems Hit By Cyberattack

By

Lumax International (TPE:6192) said certain internal information systems were hit by a cyberattack on Tuesday, according to a same-day Taiwan Exchange filing.

The company said it immediately activated its cybersecurity response mechanisms, and is working with external experts to restore affected systems.

It added that no material operational impact has been identified at this stage, and there is no evidence of data leakage or compromise of confidential information.

Lumax vowed to strengthen its cybersecurity infrastructure and expand defense measures to prevent future incidents, the filing said.

Related Articles

Asia

S&P Rates HKT Capita's Proposed US Dollar Notes BBB

S&P Global Ratings has placed a BBB long-term issue rating on HKT Capital's proposed U.S. dollar notes, according to a Tuesday release.HKT Capital and parent Hong Kong Telecommunications act as guarantors of the $3 billion medium-term note program under which the proposed notes will be issued, S&P said.The proposed notes' rating is in line with the company's issuer credit rating, considering limited subordination risk in the capital structure, S&P said.The company's rating reflects S&P's view that the group will sustain its leading status among Hong Kong's telecommunications players while maintaining steady debt leverage.The rating agency does not expect a significant change in the capital structure of Hong Kong Telecommunications and HKT Trust and HKT (HKG:6823), which fully owns the telco through HKT Group Holdings, following the issuance.The company plans to channel the proceeds from the issuance to refinance its debt maturities, the rating agency said.

$HKG:6823
Asia

Haisco Pharmaceutical to Sign Licensing Agreement with Eli Lilly

Haisco Pharmaceutical (SHE:002653) subsidiary Haisco Pharmaceutical Technology (Lhasa) and Eli Lilly will sign a licensing and research collaboration agreement for five experimental drug projects, according to a Tuesday filing with the Shenzhen bourse.Eli Lilly will obtain global exclusive rights to the projects, except in China, Hong Kong, Macau, and Taiwan, which Haisco will handle.Haisco will be entitled to up to $87 million in upfront payments for five target projects from nomination to candidate compound confirmation, as well as up to $2.97 billion after achieving clinical, regulatory, and commercialization milestones.The Chinese drug company will also receive single-digit tiered royalties on future product sales, Haisco said in a separate press release.

$SHE:002653
Asia

Market Chatter: India's Enforcement Directorate Raids Vedanta's Premises Over Royalty Payments

India's Enforcement Directorate is said to be conducting searches at some premises of mining and exploration company Vedanta (NSE:VEDL, BOM:500295), including those in Mumbai, Delhi, and Rajasthan, according to local media reports on Tuesday.The company's shares fell nearly 2% intraday on Tuesday.Reports suggest that the searches are being conducted in relation to alleged violations of the Foreign Exchange Management Act (FEMA) rules pertaining to royalty payments made by the company to its parent, Vedanta Resources."We are extending full cooperation to the authorities and are providing all information sought. The company remains committed to compliance with all applicable laws and regulations. As the matter is currently under regulatory process, we are unable to comment further at this stage," a Vedanta spokesperson was quoted as saying, according to media reports.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

$BOM:500295$NSE:VEDL